NCT07321431 is a NA clinical trial of oral administration of 2 fried eggs in Gallbladder; Functional Disturbance, sponsored by Hepatopancreatobiliary Surgery Institute of Gansu Province.

Who is sponsoring NCT07321431?

NCT07321431 is sponsored by Hepatopancreatobiliary Surgery Institute of Gansu Province.

What drugs are being tested in NCT07321431?

Interventions in NCT07321431: oral administration of 2 fried eggs, oral protein bars + 50ml olive oil.

What condition does NCT07321431 study?

NCT07321431 studies Gallbladder; Functional Disturbance.

Is NCT07321431 still recruiting?

NCT07321431 is currently recruiting now. Last updated 8 January 2026.

Last reviewed 2026-01-08 · How we verify

NCT07321431

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Optimal Measurement Time for the New Gallbladder Function Assessment Method

Recruiting now NA Last updated 8 January 2026

What this trial tests

NA trial testing oral administration of 2 fried eggs in Gallbladder; Functional Disturbance in 120 participants. Currently enrolling.

Timeline

7 January 2026

Primary endpoint
20 December 2026

20 December 2026

Quick facts

Lead sponsor	Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	diagnostic
Enrollment	120
Start date	7 January 2026
Primary completion	20 December 2026
Estimated completion	20 December 2026
Sites	5 locations across China

Drugs / interventions tested

oral administration of 2 fried eggs
oral protein bars + 50ml olive oil

Conditions studied

Gallbladder; Functional Disturbance — all drugs for Gallbladder; Functional Disturbance →

Sponsor

Hepatopancreatobiliary Surgery Institute of Gansu Province

Who can join

Adults 18 to 70, any sex, with Gallbladder; Functional Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multicenter, prospective, randomized, double-blind, crossover study involving healthy individuals, aiming to evaluate the stability of oral protein bars + olive oil as a new method for determining gallbladder contraction function and its optimal diagnostic time window.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hepatopancreatobiliary Surgery Institute of Gansu Province trials

Trials by the same sponsor.

NCT03104569 — Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma · NA · not yet recruiting
NCT07091526 — Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer · recruiting
NCT07039864 — A Novel Strategy for Evaluating Gallbladder Contraction Function by Ultrasound · NA · completed
NCT06697405 — Impact of Cardiopulmonary Bypass Time on Gastrointestinal Complications · completed
NCT06699030 — A Strategy for Gallstone Expulsion Through Dietary Therapy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07321431 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hepatopancreatobiliary Surgery Institute of Gansu Province
Last refreshed: 8 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07321431.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing